This company listing is no longer active
Pfizer Management
Management criteria checks 3/4
Key information
Albert Bourla
Chief executive officer
US$24.4m
Total compensation
CEO salary percentage | 6.9% |
CEO tenure | 4.2yrs |
CEO ownership | 0.007% |
Management average tenure | 3.6yrs |
Board average tenure | 6.1yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2022 | n/a | n/a | US$31b |
Oct 02 2022 | n/a | n/a | US$30b |
Jul 03 2022 | n/a | n/a | US$29b |
Apr 03 2022 | n/a | n/a | US$25b |
Dec 31 2021 | US$24m | US$2m | US$22b |
Oct 03 2021 | n/a | n/a | US$19b |
Jul 04 2021 | n/a | n/a | US$12b |
Apr 04 2021 | n/a | n/a | US$9b |
Dec 31 2020 | US$21m | US$2m | US$7b |
Sep 27 2020 | n/a | n/a | US$212m |
Jun 28 2020 | n/a | n/a | US$7b |
Mar 29 2020 | n/a | n/a | US$9b |
Dec 31 2019 | US$18m | US$2m | US$11b |
Sep 29 2019 | n/a | n/a | US$16b |
Jun 30 2019 | n/a | n/a | US$13b |
Mar 31 2019 | n/a | n/a | US$11b |
Dec 31 2018 | US$10m | US$1m | US$4b |
Sep 30 2018 | n/a | n/a | US$24b |
Jul 01 2018 | n/a | n/a | US$23b |
Apr 01 2018 | n/a | n/a | US$22b |
Dec 31 2017 | US$9m | US$1m | US$21b |
Oct 01 2017 | n/a | n/a | US$10b |
Jul 02 2017 | n/a | n/a | US$8b |
Apr 02 2017 | n/a | n/a | US$7b |
Dec 31 2016 | US$9m | US$1m | US$7b |
Compensation vs Market: Albert's total compensation ($USD24.35M) is above average for companies of similar size in the Swedish market ($USD2.50M).
Compensation vs Earnings: Albert's compensation has been consistent with company performance over the past year.
CEO
Albert Bourla (60 yo)
4.2yrs
Tenure
US$24,353,219
Compensation
Dr. Albert Bourla, DVM, Ph.D. serves as the Chief Executive Officer of Pfizer Inc. since January 1, 2019 and has been its Executive Director since February 23, 2018. Dr. Bourla was Chief Operating Officer...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 4.2yrs | US$24.35m | 0.0074% $ 176.1m | |
Chief Scientific Officer and President of Worldwide Research | 4.2yrs | US$10.91m | no data | |
Executive VP & General Counsel | 9.3yrs | US$7.13m | 0.0032% $ 77.1m | |
Advisor | 1.6yrs | US$8.39m | 0.0054% $ 129.2m | |
Chief Commercial Officer & President of Global Biopharmaceuticals Business | 5.2yrs | US$9.03m | 0.0011% $ 26.2m | |
Chief Financial Officer & Executive VP | less than a year | no data | 0.000020% $ 475.9k | |
Senior VP | 3yrs | no data | 0.00019% $ 4.5m | |
Executive VP and Chief Digital & Technology Officer | 4.2yrs | no data | 0.00062% $ 14.8m | |
Senior VP & Chief Investor Relations Officer | 1.7yrs | no data | no data | |
Executive VP and Chief Compliance | 9.3yrs | no data | 0.0016% $ 37.6m | |
Global Chief Marketing Officer | less than a year | no data | no data | |
Chief People Experience Officer & Executive VP | 2.8yrs | no data | 0.00049% $ 11.7m |
3.6yrs
Average Tenure
56.5yo
Average Age
Experienced Management: PFE's management team is considered experienced (3.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 5.1yrs | US$24.35m | 0.0074% $ 176.1m | |
Lead Independent Director | 9.5yrs | US$405.00k | no data | |
Independent Director | 6.1yrs | US$345.00k | 0.00023% $ 5.5m | |
Independent Director | 15.5yrs | US$365.00k | 0.00018% $ 4.3m | |
Independent Director | 8.8yrs | US$365.00k | 0.000060% $ 1.4m | |
Member of Emerging Markets Advisory Board | no data | no data | no data | |
Independent Director | 3yrs | US$339.35k | no data | |
Independent Director | 5yrs | US$350.90k | no data | |
Independent Director | 3.1yrs | US$355.00k | no data | |
Independent Director | 3.8yrs | US$365.00k | 0.000070% $ 1.7m | |
Independent Director | 7.8yrs | US$365.00k | no data | |
Independent Director | 11.3yrs | US$385.00k | no data |
6.1yrs
Average Tenure
63.5yo
Average Age
Experienced Board: PFE's board of directors are considered experienced (6.1 years average tenure).